Li Jie, Zhao Bo, Liu Sanmei, Li Fang, Dong Wentao, Zhong Jie
Department of Ophthalmology, Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
J Ophthalmol. 2018 Sep 16;2018:7535043. doi: 10.1155/2018/7535043. eCollection 2018.
To retrospectively compare the safety and effectiveness of 27-gauge (27G) microincision vitrectomy surgery (MIVS) with 25-guage (25G) MIVS for the treatment of primary rhegmatogenous retinal detachment (RRD) with silicone oil tamponade.
Ninety-two patients with RRD who underwent MIVS from May 1, 2015, to June 30, 2017, were included in this study. Fifty-eight eyes underwent 25G MIVS and 34 eyes underwent 27G MIVS. We analyzed the characteristics of the patients, surgical time, main clinical outcomes, and rate of complications.
The mean surgical time was 56.7 ± 35.9 min for the 25G MIVS and 55.7 ± 36.1 min for the 27G MIVS, and there was no significant difference (=0.894) between the two groups. The primary anatomical success rate after a single operation was 94.8% for 25G MIVS and 91.2% for 27G MIVS (=0.666). Baseline and final visit best-corrected visual acuity (BCVA) were 1.9 ± 1.1 and 1.0 ± 0.8 in the 25G group, and 1.7 ± 1.0 and 1.1 ± 0.8 in the 27G group. Last visit BCVA increased significantly in both groups ( < 0.001). However, there were no significant differences in terms of visual improvement ratio (>0.2 logMAR) between the two groups (=0.173). No severe intraoperative complication was observed. Iatrogenic retinal breaks occurred in 2 eyes (3.4%) in the 25G group and 1 eye (2.9%) in the 27G group during the peripheral vitreous base shaving. The transient ocular hypertension (>25 mmHg) within postoperative week 1 was 25.9% in the 25G group and 11.8% in the 27G group (=0.120).
This study found no significant anatomical or functional difference between 27G and 25G MIVS in the treatment of primary RRD. Therefore, 27G vitrectomy appears to be a safe and effective surgery for the treatment of primary RRD.
回顾性比较27G微切口玻璃体切除术(MIVS)与25G MIVS治疗原发性孔源性视网膜脱离(RRD)并硅油填充的安全性和有效性。
纳入2015年5月1日至2017年6月30日期间接受MIVS治疗的92例RRD患者。58眼接受25G MIVS,34眼接受27G MIVS。分析患者特征、手术时间、主要临床结局及并发症发生率。
25G MIVS的平均手术时间为56.7±35.9分钟,27G MIVS为55.7±36.1分钟,两组间差异无统计学意义(=0.894)。单次手术后25G MIVS的初次解剖成功率为94.8%,27G MIVS为91.2%(=0.666)。25G组基线和末次随访时的最佳矫正视力(BCVA)分别为1.9±1.1和1.0±0.8,27G组分别为1.7±1.0和1.1±0.8。两组末次随访时BCVA均显著提高(<0.001)。然而,两组间视力改善率(>0.2 logMAR)差异无统计学意义(=0.173)。未观察到严重术中并发症。25G组在周边玻璃体基底部切除术中发生医源性视网膜裂孔2眼(3.4%),27G组1眼(2.9%)。术后第1周内短暂性眼压升高(>25 mmHg)在25G组为25.9%,27G组为11.8%(=0.120)。
本研究发现27G与25G MIVS治疗原发性RRD在解剖或功能上无显著差异。因此,27G玻璃体切除术似乎是治疗原发性RRD的一种安全有效的手术方法。